Enzon Pharmaceuticals, Inc. (ENZN)

Market Cap	4.46M -58.6%
Revenue (ttm)	n/a
Net Income	-3.69M
EPS	-0.05
Shares Out	74.21M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	172,787
Average Volume	85,755
Open	0.0600
Previous Close	0.0553
Day's Range	0.0600 - 0.0650
52-Week Range	0.0310 - 0.1299
Beta	0.17
RSI	47.41
Earnings Date	Feb 20, 2026

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its patented drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1981
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ENZN